NeuroPace, Inc. (NPCE)
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
$14.90+1.02%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
QuarterlyIQ Insights · NPCE
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|---|
| Revenues | |||||||
| Revenues | 102.9 | 100.0 | 79.9 | 65.4 | 45.5 | 45.2 | 41.1 |
| Cost of Revenues | 22.2 | 22.8 | 20.8 | 17.3 | 13.0 | 11.7 | 10.9 |
| Gross Profit | 80.6 | 77.2 | 59.1 | 48.1 | 32.5 | 33.4 | 30.3 |
| Operating Expenses & Income | |||||||
| Selling, General & Admin | — | — | 57.1 | 54.5 | 51.3 | 39.0 | 27.6 |
| R&D Expenses | 27.7 | 27.9 | 23.7 | 20.8 | 21.9 | 18.2 | 15.7 |
| Operating Income | (13.7) | (16.3) | (21.7) | (27.2) | (40.8) | (23.7) | (13.1) |
| Earnings from Continuing Operations | |||||||
| Interest Expense | — | 7.5 | 8.8 | 8.5 | 7.5 | 7.4 | 11.5 |
| Interest & Investment Income | 2.4 | 2.8 | 3.0 | 3.1 | 1.6 | 0.4 | 0.0 |
| Net Interest Expenses | — | — | — | 5.5 | 6.0 | 7.0 | 11.4 |
| Net Income | |||||||
| Net Income | (19.1) | (21.5) | (27.1) | (33.0) | (47.1) | (36.1) | (24.3) |
| Per Share | |||||||
| Basic EPS | (0.56) | (0.66) | (0.93) | (1.27) | (1.91) | (2.17) | (117.85) |
| Diluted EPS | (0.56) | (0.66) | (0.93) | (1.27) | (1.91) | (2.17) | (117.85) |
| Revenue per Share | 3.02 | — | — | — | — | — | — |
| Dividend per Share | — | — | — | 0.00 | — | — | — |
| Basic Weighted Avg Shares | 34.1 | 32.7 | 29.1 | 25.9 | 24.6 | 16.6 | 0.2 |
| Diluted Weighted Avg Shares | 34.1 | 32.7 | 29.1 | 25.9 | 24.6 | 16.6 | 0.2 |
| Supplemental | |||||||
| EBIT | (13.7) | (16.3) | (21.7) | (27.2) | (40.8) | (23.7) | (13.1) |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.